IPO Trending
MONOPHARMASME / NSEListed

Mono Pharmacare Limited

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

₹26 - ₹2813.47x sub
Listed Price29.00
Listing Gain+3.57%
Subscription13.47x total demandUpdated 07 Nov 2025, 08:54 AM
QIB10.89x
Hot Bidding (High Profits)Offered: 5,00,000 sh
Nib8.12x
Popular / Warm DemandOffered: 22,60,000 sh
Retail19.39x
Hot Bidding (High Profits)Offered: 22,64,000 sh
CategoryOfferedAppliedTimes
QIB5,00,00054,44,00010.89x
Nib22,60,0001,83,48,0008.12x
Retail22,64,0004,38,88,00019.39x
Segment Subscription Demand
Segment / CategoryDemand (Shares)Offered (Shares)Times Sub.
QIB15.241.410.89x
Retail122.896.3419.38x
Mono Pharmacare Limited IPO Subscription | GMP, Allotment & Financials | IPO Trending